Labcorp Insider Trades
NYSE: LHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 17 · $10.36M
- Shares bought / sold
- 0 / 36.25K
- Net activity
- Net selling $10.4 million
Labcorp insider activity
Over the last 12 months, Labcorp insiders reported 76 transactions on SEC Form 4: 0 open-market purchases and 17 sales. Insiders bought $0 and sold $10.4 million worth of stock, for net insider selling of $10.4 million. The largest seller was Schechter Adam H, with $6.9 million in reported sales.
The most recent filing shows ANDERSON KERRII B (Director) selling 3,000 shares at $318.02 on Aug 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LH's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LH insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 17, 2026 | ANDERSON KERRII BDirector | Sale | 3,000 | $954.06K | Form 4 |
| Aug 11, 2026 | Schechter Adam HPresident & CEO | Sale | 4,669 | $1.50M | Form 4 |
| Aug 4, 2026 | Summy Amy B.EVP, Chief Marketing Officer | Sale | 924 | $283.43K | Form 4 |
| Aug 3, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Sale | 1,338 | $413.75K | Form 4 |
| Aug 3, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Option exercise | 1,338 | $279.98K | Form 4 |
| Aug 3, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Sale | 82 | $25.36K | Form 4 |
| Jul 2, 2026 | Vaughn Bryan TEVP and President, Diagnostics | Sale | 234 | $66.97K | Form 4 |
| Jul 2, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Sale | 92 | $26.33K | Form 4 |
| Jul 1, 2026 | Vaughn Bryan TEVP and President, Diagnostics | Tax withholding | 93 | $26.40K | Form 4 |
| Jul 1, 2026 | Vaughn Bryan TEVP and President, Diagnostics | Option exercise | 327 | — | Form 4 |
| Jul 1, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Tax withholding | 73 | $20.72K | Form 4 |
| Jul 1, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Option exercise | 256 | — | Form 4 |
| Jun 8, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Sale | 762 | $201.08K | Form 4 |
| May 11, 2026 | Schechter Adam HPresident & CEO | Sale | 5,903 | $1.50M | Form 4 |
| Mar 27, 2026 | Meltzer Jonathan CEVP, Operations | Sale | 839 | $224.05K | Form 4 |
| Mar 27, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Sale | 1,633 | $436.09K | Form 4 |
| Mar 26, 2026 | Meltzer Jonathan CEVP, Operations | Tax withholding | 711 | $190.82K | Form 4 |
| Mar 26, 2026 | Meltzer Jonathan CEVP, Operations | Award | 2,388 | — | Form 4 |
| Mar 26, 2026 | Oyegunwa AkinboladeEVP, CIO & CTO | Tax withholding | 382 | $102.52K | Form 4 |
| Mar 26, 2026 | Oyegunwa AkinboladeEVP, CIO & CTO | Award | 1,340 | — | Form 4 |
| Mar 26, 2026 | Summy Amy B.EVP, Chief Marketing Officer | Tax withholding | 1,836 | $492.75K | Form 4 |
| Mar 26, 2026 | Summy Amy B.EVP, Chief Marketing Officer | Award | 3,994 | — | Form 4 |
| Mar 26, 2026 | Bailey Megan D.EVP, Pres, Central Labs & Intl | Tax withholding | 481 | $129.09K | Form 4 |
| Mar 26, 2026 | Bailey Megan D.EVP, Pres, Central Labs & Intl | Award | 1,184 | — | Form 4 |
| Mar 26, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Tax withholding | 451 | $121.04K | Form 4 |
| Mar 26, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Award | 1,584 | — | Form 4 |
| Mar 26, 2026 | Vaughn Bryan TEVP, Diagnostics | Tax withholding | 451 | $121.04K | Form 4 |
| Mar 26, 2026 | Vaughn Bryan TEVP, Diagnostics | Award | 1,584 | — | Form 4 |
| Mar 26, 2026 | van der Vaart Sandra DEVP, Corporate Affairs | Tax withholding | 2,722 | $730.53K | Form 4 |
| Mar 26, 2026 | van der Vaart Sandra DEVP, Corporate Affairs | Award | 6,382 | — | Form 4 |
| Mar 26, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Tax withholding | 755 | $202.63K | Form 4 |
| Mar 26, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Award | 2,388 | — | Form 4 |
| Mar 26, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | Tax withholding | 863 | $231.61K | Form 4 |
| Mar 26, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | Award | 1,986 | — | Form 4 |
| Mar 26, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | Tax withholding | 4,042 | $1.08M | Form 4 |
| Mar 26, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | Award | 9,304 | — | Form 4 |
| Mar 26, 2026 | Schroeder Mark SEVP, Pres Diagnostics & COO | Tax withholding | 1,468 | $393.98K | Form 4 |
| Mar 26, 2026 | Schroeder Mark SEVP, Pres Diagnostics & COO | Award | 2,968 | — | Form 4 |
| Mar 26, 2026 | Schroeder Mark SEVP, Pres Diagnostics & COO | Tax withholding | 4,600 | $1.23M | Form 4 |
| Mar 26, 2026 | Schroeder Mark SEVP, Pres Diagnostics & COO | Award | 9,304 | — | Form 4 |
| Mar 26, 2026 | Schechter Adam HPresident & CEO | Tax withholding | 26,106 | $7.01M | Form 4 |
| Mar 26, 2026 | Schechter Adam HPresident & CEO | Award | 58,470 | — | Form 4 |
| Mar 26, 2026 | GRAHAM ANITA ZEVP, CHRO | Tax withholding | 2,879 | $772.67K | Form 4 |
| Mar 26, 2026 | GRAHAM ANITA ZEVP, CHRO | Award | 6,604 | — | Form 4 |
| Mar 3, 2026 | Schechter Adam HPresident & CEO | Sale | 8,705 | $2.44M | Form 4 |
| Feb 27, 2026 | van der Vaart Sandra DEVP, Corporate Affairs | Sale | 548 | $156.00K | Form 4 |
| Feb 24, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | Sale | 1,500 | $429.46K | Form 4 |
| Feb 19, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Sale | 666 | $185.11K | Form 4 |
| Feb 12, 2026 | Meltzer Jonathan CEVP, Operations | Sale | 87 | $25.27K | Form 4 |
| Feb 11, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | Tax withholding | 211 | $61.17K | Form 4 |
| Feb 11, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | Option exercise | 740 | — | Form 4 |
| Feb 11, 2026 | GRAHAM ANITA ZEVP, CHRO | Tax withholding | 109 | $31.60K | Form 4 |
| Feb 11, 2026 | GRAHAM ANITA ZEVP, CHRO | Option exercise | 356 | — | Form 4 |
| Feb 11, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Tax withholding | 62 | $17.97K | Form 4 |
| Feb 11, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Option exercise | 216 | — | Form 4 |
| Feb 11, 2026 | Meltzer Jonathan CEVP, Operations | Tax withholding | 70 | $20.29K | Form 4 |
| Feb 11, 2026 | Meltzer Jonathan CEVP, Operations | Option exercise | 243 | — | Form 4 |
| Feb 11, 2026 | Oyegunwa AkinboladeEVP, CIO & CTO | Tax withholding | 68 | $19.71K | Form 4 |
| Feb 11, 2026 | Oyegunwa AkinboladeEVP, CIO & CTO | Option exercise | 230 | — | Form 4 |
| Feb 11, 2026 | Schechter Adam HPresident & CEO | Tax withholding | 1,521 | $440.92K | Form 4 |
| Feb 11, 2026 | Schechter Adam HPresident & CEO | Option exercise | 3,656 | — | Form 4 |
| Feb 11, 2026 | Schechter Adam HPresident & CEO | Sale | 5,273 | $1.50M | Form 4 |
| Feb 11, 2026 | Schroeder Mark SEVP, Pres Diagnostics & COO | Tax withholding | 259 | $75.08K | Form 4 |
| Feb 11, 2026 | Schroeder Mark SEVP, Pres Diagnostics & COO | Option exercise | 806 | — | Form 4 |
| Feb 11, 2026 | van der Vaart Sandra DEVP, Corporate Affairs | Tax withholding | 99 | $28.70K | Form 4 |
| Feb 11, 2026 | van der Vaart Sandra DEVP, Corporate Affairs | Option exercise | 376 | — | Form 4 |
| Feb 11, 2026 | Vaughn Bryan TEVP, Diagnostics | Tax withholding | 93 | $26.96K | Form 4 |
| Feb 11, 2026 | Vaughn Bryan TEVP, Diagnostics | Option exercise | 323 | — | Form 4 |
| Feb 11, 2026 | Wang Julia AijunChief Financial Officer, EVP | Tax withholding | 245 | $71.02K | Form 4 |
| Feb 11, 2026 | Wang Julia AijunChief Financial Officer, EVP | Option exercise | 860 | — | Form 4 |
| Feb 11, 2026 | Summy Amy B.EVP, Chief Marketing Officer | Tax withholding | 83 | $24.06K | Form 4 |
| Feb 11, 2026 | Summy Amy B.EVP, Chief Marketing Officer | Option exercise | 230 | — | Form 4 |
| Feb 11, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Tax withholding | 46 | $13.33K | Form 4 |
| Feb 11, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Option exercise | 160 | — | Form 4 |
| Feb 11, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Tax withholding | 160 | $46.38K | Form 4 |
| Feb 11, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Option exercise | 536 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4